G S Wu Selected Research

G S Wu Research Topics

Disease

7	Burns 01/2022 - 01/2017
5	Neoplasms (Cancer) 01/2022 - 01/2000
3	Shock 02/2021 - 05/2020
2	Breast Neoplasms (Breast Cancer) 05/2022 - 10/2021
2	Inflammation (Inflammations) 11/2020 - 01/2019
2	Sepsis (Septicemia) 10/2020 - 01/2019
2	Lung Neoplasms (Lung Cancer) 11/2001 - 01/2001
1	Lymphedema (Milroy Disease) 05/2022
1	Fibrosis (Cirrhosis) 05/2022
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 05/2022
1	Pneumonia (Pneumonitis) 05/2022
1	Lung Injury 05/2022
1	Acute Lung Injury 05/2022
1	Inhalation Burns 01/2022
1	Flushing 11/2021
1	Mastitis 11/2021
1	Smoke Inhalation Injury 04/2021
1	Respiratory Tract Infections (Respiratory Tract Infection) 04/2021
1	Wounds and Injuries (Trauma) 04/2021
1	Pulmonary Edema 11/2020
1	Ovarian Neoplasms (Ovarian Cancer) 10/2017
1	Cicatrix (Scar) 01/2017
1	Contracture 01/2017
1	Infections 01/2017
1	Diarrhea 01/2017
1	Intestinal Volvulus (Volvulus) 01/2017
1	Abdominal Abscess 05/2015
1	Colonic Neoplasms (Colon Cancer) 11/2001
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2001
1	Uveitis 01/2000
1	Blindness (Hysterical Blindness) 01/2000

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 10/2017 - 01/2000
2	CytokinesIBA 01/2019 - 01/2000
2	CaspasesIBA 01/2001 - 01/2000
1	AntioxidantsIBA 05/2022
1	Myosins (Myosin)IBA 05/2022
1	LipopolysaccharidesIBA 05/2022
1	EndotoxinsIBA 05/2022
1	Eosine Yellowish-(YS) (Eosin)IBA 05/2022
1	Hematoxylin (Haematoxylon)IBA 05/2022
1	Therapeutic UsesIBA 11/2021
1	PlasticsIBA 11/2021
1	SmokeIBA 04/2021
1	fibrin fragment D (D-dimer)IBA 02/2021
1	formycin diphosphate (FDP)IBA 02/2021
1	Fibrinogen (Factor I)FDA Link 02/2021
1	Hemostatics (Antihemorrhagics)IBA 02/2021
1	Vasoconstrictor AgentsIBA 11/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2020
1	AngiopoietinsIBA 10/2020
1	human AZU1 proteinIBA 10/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2020
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 10/2020
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Platinum Compounds (Compounds, Platinum)IBA 10/2017
1	Cisplatin (Platino)FDA LinkGeneric 10/2017
1	Botulinum Toxins (Botulinum Toxin)IBA 01/2017
1	SiliconesIBA 01/2017
1	AntibodiesIBA 01/2017
1	Messenger RNA (mRNA)IBA 11/2001
1	QuinoxalinesIBA 11/2001
1	Phosphotransferases (Kinase)IBA 11/2001
1	XK 469 (XK469)IBA 11/2001
1	propionic acid (potassium propionate)IBA 11/2001
1	AcidsIBA 11/2001
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2001
1	TNF-Related Apoptosis-Inducing LigandIBA 01/2001
1	Cytochromes c (Cytochrome c)IBA 01/2001
1	Free RadicalsIBA 01/2000
1	Oxidants (Oxidizing Agents)IBA 01/2000
1	Cytotoxins (Cytolysins)IBA 01/2000
1	fas Receptor (CD95 Antigen)IBA 01/2000
1	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 01/2000
1	Retinaldehyde (Retinal)IBA 01/2000
1	Retinal Pigments (Pigments, Visual)IBA 01/2000

Therapy/Procedure

4	Transplantation 05/2022 - 05/2015
4	Tracheotomy 01/2022 - 01/2020
2	Lymph Node Excision (Lymph Node Dissection) 05/2022 - 10/2021
2	Resuscitation 11/2020 - 05/2020
2	Skin Transplantation (Skin Grafting) 11/2020 - 01/2017
2	Therapeutics 01/2017 - 01/2000
1	Autologous Transplantation 01/2022
1	Operative Surgical Procedures 11/2021
1	Length of Stay 04/2021
1	Artificial Respiration (Mechanical Ventilation) 04/2021
1	Emergency Treatment 11/2020
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2017
1	Lasers (Laser) 01/2017
1	Orthotic Devices (Orthosis) 01/2017
1	Tissue Transplantation 01/2017
1	Physical Therapy Modalities (Physical Therapy Technique) 01/2017
1	Molecular Targeted Therapy 01/2017
1	Drug Therapy (Chemotherapy) 05/2001